BSI 23/30427228 DC 2023
$13.70
BS ISO 20688-2. Biotechnology. Nucleic acid synthesis – Part 2. General definitions and requirements for the production and quality control of synthesized gene fragments, genes, and genomes
Published By | Publication Date | Number of Pages |
BSI | 2023 | 36 |
PDF Catalog
PDF Pages | PDF Title |
---|---|
1 | 30427228-NC.pdf |
3 | ISO_DIS 20688-2 ed.1 – id.75852 Enquiry PDF (en).pdf |
7 | Foreword |
8 | Introduction |
9 | 1 Scope 2 Normative references 3 Terms and definitions |
12 | 4 General requirements for quality management 4.1 General requirements 4.2 Control of documents |
13 | 4.3 Quality management system 4.4 Biorisk management and safety control |
14 | 5 Requirements for resource management 5.1 Facilities and environmental condition 5.2 Equipment and instruments 5.3 Raw materials |
15 | 5.4 Personnel 6 Biosafety and biosecurity requirements 6.1 General 6.2 DNA sequence screening mechanism 7 Requirements for quality control in production 7.1 General |
16 | 7.2 Quality control in synthetic gene fragments production 7.2.1 General 7.2.2 Sequence design 7.2.3 Assembly 7.2.4 Purification 7.2.5 Product preservation 7.3 Quality control in synthetic gene production 7.3.1 General |
17 | 7.3.2 Colony Screening 7.3.3 DNA preparation from the host cell 7.3.4 Sequence Verification 7.3.5 Product preservation 7.4 Quality control in synthetic genome production 7.4.1 General |
18 | 7.4.2 Assembly 7.4.3 Sequence verification 8 Requirements for product quality 8.1 Synthetic gene fragments 8.1.1 General 8.1.2 Yield 8.1.3 Purity 8.1.4 Size |
19 | 8.1.5 Gene cloning accuracy 8.2 Synthetic genes 8.2.1 General 8.2.2 Yield 8.2.3 Purity 8.2.4 Sequence 8.2.5 Integrity |
20 | 8.2.6 Residual impurities analysis 8.2.7 Supercoiled plasmid 8.2.8 Bioburden 8.2.9 Specific quality indicators for synthetic DNA libraries |
21 | 8.3 Synthetic genome 8.3.1 General 8.3.2 sequence 9 Delivered/Synthesized Material Specifications |
22 | Annex€A (informative) Equipment and device list and control requirements |
24 | Annex€B (informative) Exemplary quality measurement methods |
26 | Annex€C (informative) Electrophoretogram |
29 | Annex€D (informative) Sanger sequencing |
30 | Annex€E (informative) Massively Parallel Sequencing (MPS) |
33 | Annex€F (informative) Additional quality control options for synthetic gene fragments |
34 | Annex€G (informative) The ranks of the risk posed by DNA products |
35 | Bibliography |